Knoll Capital Management as of Sept. 30, 2014
Portfolio Holdings for Knoll Capital Management
Knoll Capital Management holds 14 positions in its portfolio as reported in the September 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Medivation | 87.2 | $222M | 2.2M | 98.87 | |
| Ampio Pharmaceuticals | 4.7 | $12M | 3.4M | 3.56 | |
| Alcobra | 4.2 | $11M | 687k | 15.44 | |
| Keryx Biopharmaceuticals | 1.1 | $2.8M | 200k | 13.75 | |
| Synthetic Biologics | 0.9 | $2.4M | 1.4M | 1.76 | |
| Newlink Genetics Corporation | 0.7 | $1.7M | 77k | 21.42 | |
| Inovio Pharmaceuticals | 0.4 | $1.0M | 102k | 9.85 | |
| Advaxis | 0.3 | $756k | 225k | 3.36 | |
| Galmed Pharmaceuticals | 0.2 | $559k | 65k | 8.60 | |
| Northwest Biotherapeutics In (NWBO) | 0.1 | $337k | 67k | 5.03 | |
| Nephrogenex | 0.1 | $234k | 50k | 4.68 | |
| Provectus Biopharmaceuticals I (PVCT) | 0.1 | $204k | 200k | 1.02 | |
| Advaxis | 0.1 | $162k | 113k | 1.44 | |
| Cellectar Biosciences | 0.0 | $33k | 15k | 2.26 |
